Curio Digital Therapeutics, a leading provider of digital therapeutics, will be attending AHIP’s annual conference in Portland, Oregon from June 13th to the 15th and hosting a kiosk. The kiosk will showcase Curio’s innovative digital forward platforms, which are designed to help women manage their behavioral health during key reproductive phases.
“We are excited to be participating in AHIP’s annual conference,” said Shailja Dixit, Founder & CEO of Curio Digital Therapeutics. “This is a great opportunity for us to connect with health plans and share our vision to provide a digital forward solution for this vulnerable population. We believe that our platforms have the potential to revolutionize the way that women’s behavioral health is managed.”
Curio’s flagship product, MamaLiftTM, is a mobile application program intended to be used by women, as part of a healthy lifestyle, to help reduce their risk of depression and anxiety during pregnancy or after delivery. It features clinically validated screenings, neurobehavioral interventions, and elements of gamification. These digital elements are augmented by the Curio Care Network, which facilitates live health coaching and escalates patients to therapists as needed.
“We are committed to providing patients with the tools they need to manage their behavioral health,” said Shailja Dixit. “Our digital forward platforms are designed to be easy to use and are very engaging, and we believe that they can transform the trajectory of women’s behavioral health.”
Curio Digital Therapeutics is a privately held company headquartered in Princeton, New Jersey. The company was founded in 2019 by a team of experienced healthcare professionals and entrepreneurs.
About Curio Digital Therapeutics
Curio Digital is a pioneer in developing digital therapeutics solutions and interventions across the behavioral health continuum for women throughout the cycle of life. Curio aims to create a world where every woman can access a behavioral health solution at her fingertips. Curio is reshaping maternal mental health care by leveraging proprietary algorithms, clinically validated screening tools, and personalized digital behavioral interventions to facilitate timely identification and care. Curio’s products include MamaLift, focused on pregnancy and postpartum, FertiLift, an extension of fertility clinics providing behavioral health support, and Ferticalm, delivering support directly to patients during fertility treatments. For more information, visit Curio at www.curiodigitaltx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230607005742/en/